Pharmacovigilance – News and Features

The study was aimed at investigating safety/tolerability, pharmacokinetics, and pharmacodynamics during prolonged dosing with EVT 302 as compared to placebo.

Compound 642444 and compound 685698 advance in clinical development for the treatment of asthma.

Discovery is a step closer to a universal stem cell line for human therapeutics and creation of a global stem cell bank.

Stealth Biotech announced today its plans to target specific microRNA:mRNA interactions for development of novel oligonucleotide-based therapeutics.

Evotec AG and Renovis, Inc. today announced that they have entered into a definitive agreement under which Evotec will acquire Renovis, a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of pain and inflammatory diseases, in a stock-for-stock transaction valued at approximately US$ 151.8 million.

Southern Illinois University’s researchers presented the results of a study using nab-paclitaxel and bevacizumab to treat lymphatic and pulmonary metastases in female SCID mice.

The Company finalized its Phase IIb Oxycyte clinical trial and plans to initiate three pre-clinical animal studies in sickle cell disease, spinal cord injury and stroke in the first half of 2008.

Alliance will accelerate launch of new animal-free supplements and provide customers with a source of high performance cell culture products.

A mouse resistant to cancer, even highly-aggressive types, has been created by researchers at the University of Kentucky. The breakthrough stems from a discovery by UK College of Medicine professor of radiation medicine Vivek Rangnekar and a team of researchers who found a tumor-suppressor gene called "Par-4" in the prostate.

Measures to protect astronauts from health risks caused by space radiation will be important during extended missions to the moon or Mars, say researchers.